There is an inverted U-shaped association between sleep duration and global cognitive decline.
Improvements in lifestyle risk factors for dementia can lead to short-term improvements in cognition among community-dwelling adults experiencing cognitive decline.
Anticholinergic medications are associated with an increased risk for incident mild cognitive impairment and cognitive decline in older adults.
Adults who experience more episodes of moderate/high end-stage renal disease risk have worse performance in cognitive domains in middle age.
Simple coping behaviors may protect against anxiety and depressive symptoms during the COVID-19 pandemic and lockdown.
Compared to routine EEG, continuous EEG increased seizure detection and guided antiseizure treatment, but was not associated with improved outcomes.
Sleep abnormalities and cognition in bipolar disorder may be related, and may affect cognition in this patient population.
MRI-based cerebrovascular reactivity is associated with cognitive function independent of Alzheimer disease pathology.
The Lancet Commission added 3 new risk factors for dementia that coupled with the previous 9 lifestyle risk factors might prevent or delay up to 40% of dementias worldwide.
Investigators conducted a population-based study in which a survey was deployed to assess the impact of the COVID-19 pandemic on mental health and well-being.